{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":20,"n_cols":5,"rows_kept":20,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[13,2,13,3],[14,2,14,3],[18,2,18,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910962058303321"]
[null,null,"Titolo",null,"Establishing precompetitive collaborations to stimulate genomics-driven product development : workshop summary / / Institute of Medicine of the National Academies ; Steve Olson and Adam C. Berger, rapporteurs"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C., : National Academies Press, 2011"]
[null,null,"ISBN",null,"0-309-20961-7"]
[{"$nulls":4},"1-283-01913-2"]
[{"$nulls":4},"9786613019134"]
[{"$nulls":4},"0-309-16183-5"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"xv, 74 p. : ill. (some col.)"]
[null,null,"Disciplina",null,"576.5"]
[null,null,"Soggetti",null,"Pharmacogenetics"]
[{"$nulls":4},"Drug development"]
[{"$nulls":4},"Genomics"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy.\""]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"Introduction -- A lesson about precompetitive collaboration -- Requisites for successful precompetitive collaboration -- Frameworks for collaboration -- The use of biospecimens in precompetitive collaborations -- Ethical challenges in the use of biospecimens -- Toward developing a cultural, legal, and behavioral framework for precompetitive collaboration."]
[null,null,null,"Sommario/riassunto","\"Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts. The Institute of Medicine held a workshop on July 22, 2010, to explore these issues and develop solutions.\"--Publisher's description."]